The Silicon Review ^Asia

This move will help the company with its medicine activities in the APAC region

BC Platforms has announced that it is expanding its R&D operations in healthcare data management and analytics in Singapore. This move will help the company with its medicine activities in the APAC region.

Along with the announcement of R&D expansion, the company is also forging a research partnership with Singapore Health Services ('SingHealth'). Under this partnership, SingHealth has joined BCP's BCRQUEST global data network, in a research partnership to accelerate the genetic understanding and clinical research of diseases prevalent in Asian cohorts.

The company has picked Niko Hurskainen, Chief Technology Officer of BCP, to head the R&D Center in Singapore. In a statement, Mr. Hurskainen said: "While TRE R&D leadership stays at the heart of the TRE concept in the UK, our Singapore R&D Centre, which is fully integrated with local healthcare and research institutions, will be core to our continued effort to deliver leading locally relevant user experiences on top of leading data management, scalability and privacy capabilities. Additionally, we see the region as a great location for building and scaling our global R&D organisation to support a global customer base."

The company's move to setup a R&D Center in Singapore will help it move its mission along to deliver industry-leading interpretation services on genomics related insights, including pharmacogenomics in clinical practice in Asia and around the world.